Celox

 

Topic mentions per year

Topic mentions per year

2009-2017
024620092017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
BACKGROUND Uncontrolled hemorrhage is a well-recognized cause of mortality in trauma victims and the control of active hemorrhage… (More)
  • table 1
  • table 2
  • figure 1
Is this relevant?
2014
2014
The aim of this study is to evaluate the effect of these new generation hemostatic agents on early-stage soft tissue healing of… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
2012
2012
Haemorrhage from severe pelvic fractures can be associated with significant mortality. Modern civilian trauma centres may manage… (More)
Is this relevant?
2011
2011
The use of Celox, a chitosan-based haemostatic agent, for the control of massive traumatic bleeding in patients arriving at a… (More)
  • table 1
Is this relevant?
2011
2011
BACKGROUND The purpose of this study was to evaluate the efficacy of zeolite- and chitosan-based local hemostatic agents for the… (More)
Is this relevant?
2010
2010
The purpose of this study was to compare the effectiveness of 2 hemostatic agents, chitosan-based Celox and the biopolymeric… (More)
  • figure 1
  • figure 2
Is this relevant?
2010
2010
BACKGROUND Hemorrhage is the second leading cause of death in civilian trauma and the leading cause of preventable death in… (More)
  • table 1
Is this relevant?
2009
2009
Celox (MedTrade Products Ltd, Cheshire, UK) is a proprietary preparation of chitosan, indicated for moderate to severe hemorrhage… (More)
Is this relevant?
2009
2009
BACKGROUND Major improvements have been made in the development of novel dressings with hemostatic properties to control heavy… (More)
Is this relevant?
2009
2009
BACKGROUND The use of mineral (clay) or biologic (chitosan) materials has improved the efficacy of dressings used in the bleeding… (More)
  • table I
  • table II
  • figure 1
  • table II
  • figure 2
Is this relevant?